23 - Repro tox Flashcards

(33 cards)

1
Q

What is Teratology

A

Investigation of causes and mechanisms of congenital developmental disorders (CDD)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Congenital developmental disorders caused by…

A
  1. Genetic (Down’s syndrome)
  2. Injury (birth)
  3. Chem (Thalidomide)
  4. Infection
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

James G. Wilson’s 6 principles of teratology

A
  1. Genotype of conceptus
  2. Developmental stage at time of exposure
  3. MOA abnormal developmental events
  4. Nature of influence
  5. 4 manifestations of deviant devel.
  6. Frequency and Dose
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

The 4 manifestations of deviant development

A
  1. Death
  2. Malformation,
  3. Growth retardation
  4. Impaired function.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is Thalidomide?

A

Released as sedative
* Caused severe birth defects and death
* Marketed as safe and non-addictive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

CDD caused by Thalidomide

A

Effects to eyes, ears, limbs (phocomelia), facial palsies, mental effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Biochemistry of thalidomide

A

2x linked rings (glutarimide and pthalimid)
* Chiral carbon ➔ unstable, allows 2 enantiomers to coexist
* Interchange rapidly in body fluid, water

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Thalidomide enantiomers

A

S-enantiomer is teratogenic, R-enantiomer is sedative
* Was sold as a racemic mix
* Non-teratogenic form possible

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Critical period for Thalidomide-induced birth abnormalities

A

Occur from day 21 post conception to day 36
* Early use could be ok
* Morning sickness > development of important structures (critical)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Thalidomide Mechanism of Teratogenicity

A
  1. Bind to cereblon (CRBN)
  2. Disrupt E3 ubiquitin ligase complex function
  3. ↓-reg of fibroblast growth factor genes (esp. fgf8 → key in limb devel. abnormalities)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Toxicant exposure and timing in repro cycle

A

Weeks 1 & 2 not susceptible to teratogens but spontaneous abortions common
* 1st trimester very sensitive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Sexual differentiation during gestation

A

Wk ~7 sex morphology develops
* rely on Y chromosomal control
* SRY codes protein ➔ testicular organogenesios
* Absentovaries
* Male repro devel hormone-dependentsusceptible to endocrine disruption

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How can toxicants effect ovarian histology?

A
  1. Poly-ovular follicles
  2. Oocyte depletion
  3. Interstitial cell hyperplasia
  4. Corpora albanicas
  5. Absense of corpora lutea
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Sites of action for reproductive (cycle) toxicants

A

Centrally acting catecholaminergic drugs can interfere with neuroendocrine reg.
* Hypothalamic-pituitary-gonadal (HPG) target in both sexes
* Disrupted by exogenous estrogens + PCBs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How can toxicants effect testicle histology?

A
  1. Cadmium ➔ disrupts blood supply from internal spermatic artery
  2. Melatoninregression of testes, ↓ testi steroids + mating behaviours
  3. CCl4 ➔ tox to liver → disrupt metabolism of sex steroids
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Can we use animal models to predict teratology?

A

Understanding of animal repro facilitates use to investigate potential human effects
* Comparable stages exist in non-clinical species
* Rat and Rabbit

16
Q

Two main sources of info for human repro data/effects

A
  1. Registries of cogenital abnormalities (drug/chem exposure in patient history)
  2. Teratology info services (TIS)
17
Q

EUROCAT

A

EU cogenital register
* Evaluate efficacy of safety measures (pregnancy prevention programs) for thalidomide (myeloma), isotretinoin (acne), acitretin (psoriasis)

18
Q

How can registers be used to study teratology?

A

Rates of abnormalities compared to prescribing databases
* Used to construct cohort & case-control studies
* Other exposures hard to measure

19
Q

Vitamin K antagonists

A

Required for producing clotting factors
* Antagonists (warfarin) prevent clots and strokes
* AVOID during 1st trimester

20
Q

TIS observed effects of Vit K Ant.

A
  1. Inhibit bone growth
  2. Bleeding foetus
  3. Spontaneous abortion
  4. Defects
  5. Premature and low birth weight
21
Q

TIS observed effects of Isotretinoin

A

Accidental exposure in **1st 2 weeks **after conception doesn‘t necessarily call for termination
* Ultrasound at 12 and 20 wk ➔ assess foetal condition

22
Q

TIS observed effects of AT-II antagonists

A

Impairs perfusion of foetal organs + ↓ amniotic fluid
* Not a major teratogen

23
Q

Mothersafe NSW

A

TIS for NSW
* Provide evidence-based info
* Support mothers
* Prevent termination due to misled concerns

24
The Australian categorisation system for prescribing medicines in pregnancy
*NOT* **hierarchical** * **Human** data *lacking* for drugs in **B1-3** categories (based on **animal**) * Categories **A**, **B** (1-3), **C**, **D**, **X**
25
Category A (preg drug)
***Large*** amount taken and **no** proven ↑ in ***maformations*** or ***harm*** to fetus
26
Category B1 (preg drug)
Taken by ***limited*** people * **no** proven ↑ in ***maformations*** or ***harm*** to fetus * **ANIMAL**
27
Category B2 (preg drug)
Taken by ***limited*** people * **no** proven ↑ in ***maformations*** or ***harm*** to fetus * BUT **ANIMAL** data ***inadequate*** or ***lacking***
28
Category B3 (preg drug)
Taken by ***limited*** people * **no** proven ↑ in ***maformations*** or ***harm*** to fetus * BUT **ANIMAL** data shown *evidence* of ***INCREASE***
29
Category C (preg drug)
*Have* or are suspected to *cause* **harm** on human fetus *WITHOUT* **malformations** * May be ***reversible***
30
Category D (preg drug)
*Have* or are suspected to *cause* **harm** on human fetus ***AND*** **malformations** * Sometimes ***irreversible***
31
Category X
*HIGH* risk of **permanent** damage * NOT be used ***at all*** in preg
32
Endocrine Disruptors
**Tributyltin** inhibits ➔ 1. **CYP19A1** (aromatase) ➔ *reducing* **estrogen** lvls, needed for normal ***placental*** function 2. **3β-Hydroxysteroid dehydrogenase 1** ➔ reducing **progesterone** crucial for ***maintaining*** pregnancy